Amiodarone Administration Guidelines

Introduction to Amiodarone Administration

The American College of Cardiology recommends a loading dose of 150 mg IV over 10 minutes, followed by 1 mg/min for 6 hours, then 0.5 mg/min for 18 hours, with a total dose not exceeding 2.2 g over 24 hours for amiodarone administration 1, 2, 3

The American Heart Association suggests an initial bolus of 150 mg IV over 10 minutes for life-threatening arrhythmias 1
Early maintenance infusion of 1 mg/min for 6 hours (360 mg) is recommended by the American College of Cardiology 1, 3
Later maintenance infusion of 0.5 mg/min for 18 hours (540 mg) is recommended by the American College of Cardiology 1, 3
Total dose over 24 hours should not exceed 2.2 g, as recommended by the American College of Cardiology 1, 2
Monitoring for hypotension, bradycardia, and atrioventricular block during infusion is recommended by the American Heart Association 1, 3

The American Academy of Family Physicians recommends a loading dose of 800-1,600 mg/day in divided doses until a total of 10 g has been given for ventricular arrhythmias 3, 4
Maintenance dose of 200-400 mg/day is recommended by the American Academy of Family Physicians for ventricular arrhythmias 3, 4
For atrial fibrillation, a loading dose of 600-800 mg/day in divided doses until a total of 10 g has been given is recommended by the American Academy of Family Physicians 3, 4
Maintenance dose of 200 mg/day is recommended by the American Academy of Family Physicians for atrial fibrillation 3, 4

Continuous cardiac monitoring is recommended by the American Heart Association during IV administration 1
Regular blood pressure monitoring is recommended by the American Heart Association during IV administration 1
Monitoring for hypotension, bradycardia, and AV block is recommended by the American Heart Association during IV administration 1, 3
Baseline and periodic pulmonary function tests are recommended by the American Academy of Family Physicians for long-term monitoring 3, 4
Thyroid function tests are recommended by the American Academy of Family Physicians for long-term monitoring 3, 4
Liver function tests are recommended by the American Academy of Family Physicians for long-term monitoring 3, 4
Ophthalmologic examinations are recommended by the American Academy of Family Physicians for long-term monitoring 3, 4
ECG monitoring is recommended by the American College of Cardiology for long-term monitoring 2, 3

Amiodarone has numerous drug interactions due to its effects on multiple ion channels and receptors, as noted by the American College of Cardiology 1, 5
Amiodarone has an extremely long half-life (IV: 9-36 days; Oral: 26-107 days), which can lead to accumulation and delayed onset of adverse effects, as noted by the American College of Cardiology 2
Concomitant use of other QT-prolonging medications should be done with caution, as recommended by the American College of Cardiology 2

In patients with moderate or severe left ventricular failure, use with caution as it may cause negative inotropic effects, as recommended by the American College of Cardiology 5
Amiodarone may be particularly beneficial in patients with rapid ventricular rates or impaired renal function, as noted by the American Academy of Family Physicians 3
The frequency of most adverse effects is related to total amiodarone exposure (dosage and duration of treatment), so use the lowest effective dose, as recommended by the American Academy of Family Physicians 3, 4

The American Heart Association recommends amiodarone for cardioversion to sinus rhythm, typically occurring after 6-8 hours and often requiring ≥1000 mg total dose 6
Conversion rates to sinus rhythm are 34-69% with bolus-only regimens and 55-95% with bolus plus continuous infusion 6

Amiodarone is particularly valuable in patients with structural heart disease or left ventricular dysfunction, where class IC drugs are contraindicated 6

The American Heart Association recommends administering amiodarone as a 150 mg IV bolus over 10 minutes, followed by 1 mg/min for 6 hours (360 mg), then 0.5 mg/min for 18 hours (540 mg), with a maximum total dose of 2.2 g over 24 hours 7

The American College of Cardiology states that amiodarone is relatively contraindicated in patients with significant lung disease, and if no alternative exists, the lowest effective dose and shortest duration possible should be used 7
The American Heart Association notes that amiodarone is safe in renal impairment as it undergoes hepatic metabolism, not renal excretion, and no dose adjustment is needed for renal dysfunction 7
The American College of Cardiology recommends that amiodarone is the preferred antiarrhythmic in patients with heart failure or reduced ejection fraction, as Class IC agents are contraindicated with structural heart disease 7

The American Heart Association suggests transitioning to oral amiodarone (400-600 mg daily in divided doses for 2-4 weeks, then 100-200 mg daily maintenance) when clinically appropriate 7

The American Heart Association warns that amiodarone inhibits multiple cytochrome P450 enzymes and P-glycoprotein, and dose adjustments are necessary for warfarin, digoxin, and statins 7